This inventor holds 1 USPTO granted patent. Top assignee: Trophos. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Cyrillo Drouot: Innovator in Pharmaceutical Chemistry
Introduction
Cyrillo Drouot is a notable inventor based in Draguignan, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on cholest-4-en-3-one oxime derivatives. His research focuses on developing novel chemical compounds that have potential applications as medicaments.
Latest Patents
Cyrillo Drouot holds a patent for "Cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method." This invention relates to new chemical compounds, specifically cholest-4-en-3-one oxime derivatives, and their use as cytoprotective medicaments. These compounds are particularly aimed at providing neuroprotective, cardioprotective, and hepatoprotective benefits.
Career Highlights
Drouot's career is marked by his dedication to advancing pharmaceutical science. His work has led to the development of innovative solutions that address critical health issues. He is currently associated with Trophos, a company that focuses on developing treatments for neurodegenerative diseases.
Collaborations
Cyrillo Drouot collaborates with talented professionals in his field, including Corinne Chaimbault and Rebecca Pruss. Their combined expertise contributes to the success of their projects and enhances the impact of their research.
Conclusion
Cyrillo Drouot's contributions to pharmaceutical chemistry exemplify the importance of innovation in medicine. His work on cholest-4-en-3-one oxime derivatives showcases his commitment to developing effective treatments for various health conditions.